Global Single-Cell Genome Sequencing Marke
Healthcare Services

Single-Cell Genome Sequencing Market Growth Analysis Till 2033 By The Business Research Company

The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

  • Historical Growth Drivers
    • Increased understanding of genetic heterogeneity
    • Rising demand for precision medicine
    • Increased cancer research
    • Growth in prevalence of infectious diseases
    • Increased healthcare spending
  • Forecasted Growth Drivers
    • Increasing prevalence of autoimmune diseases
    • Increasing neurological disorders
    • Increasing government initiatives and funding
    • Rise of contract research organizations (CROs)
    • Increasing awareness of scRNA-seq’s potential

Read More On The Single-Cell Genome Sequencing Market Report 2024 –

Rising Cancer Prevalence Drives Growth In Single-Cell Genome Sequencing Market

The increasing prevalence of cancer is expected to propel the growth of the single-cell genome sequencing market. Cancer, characterized by genetic alterations, can be better understood through single-cell genome sequencing, revealing genetic changes in individual cancer cells. According to the American Cancer Society, there were around 1.9 million new cancer cases and 609,360 cancer deaths in the US in 2022, with projections estimating 27.5 million new cases and 16.3 million deaths by 2040.

Technological Advancements Drive Innovations In Single-Cell Genome Sequencing Market

Technological advancements are a key trend in the single-cell genome sequencing market. Companies are focused on developing advanced solutions. For example, Mission Bio Inc. introduced the Tapestri Genome Editing Solution, offering single-cell insights for developing next-generation gene-edited drugs.

Illumina’s Acquisition Of Grail Pioneering Advancements In Genomic Healthcare

In August 2021, Illumina Inc. acquired GRAIL, a biotechnology company specializing in whole-genome sequencing. This acquisition aims to revolutionize healthcare, including cancer detection and treatment.

Market Segmentation

The single-cell genome sequencing market is segmented by:

  • Type
    • Instruments
    • Reagents
  • Technology
    • Next-Generation Sequencing (NGS)
    • Polymerase Chain Reaction (PCR)
    • Quantitative Polymerase Chain Reaction (qPCR)
    • Microarray
    • Multiple Displacement Amplification (MDA)
  • Disease Area
    • Cancer
    • Immunology
    • Prenatal Diagnosis
    • Neurobiology
    • Microbiology
    • Other Disease Areas
  • Application
    • Circulating Cells
    • Cell Differentiation Or Reprogramming
    • Genomic Variation
    • Subpopulation Characterization
    • Other Applications
  • End User
    • Academic Research Laboratories
    • Biotechnology Biopharmaceutical Companies
    • Clinics
    • Other End Users

Regional Analysis

North America was the largest region in the single-cell genome sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period.

Request for A Sample Of The Global Single-Cell Genome Sequencing Market Report: